Cannuflow

Executive Summary

Cannuflow is a privately held US medical device company founded in 1998, specializing in arthroscopy fluid management systems. The company develops and markets cannulas, sheaths, and ports that enhance visualization, reduce complications, and enable minimally invasive procedures in knee, shoulder, and hip arthroscopy. With a focus on innovation in a niche market, Cannuflow has established a presence but remains a small player. The lack of disclosed funding, valuation, or revenue data suggests limited public visibility. The company's long history without major public milestones may indicate steady but modest growth. The arthroscopy market is growing with aging populations and minimally invasive trends, presenting opportunities for Cannuflow to expand its product line or capture market share. However, intense competition from larger orthopedic device firms and the absence of recent commercial catalysts limit near-term visibility.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation fluid management system60% success
• Q4 2026Distribution partnership with a major orthopedic company30% success